A key FDA committee meets Friday to review the one-dose COVID vaccine from J&J. Authorization for its use in the US is expected to swiftly follow.
A key FDA committee meets Friday to review the one-dose COVID vaccine from J&J. Authorization for its use in the US is expected to swiftly follow.
Please to comment